| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/1999 | CN1222079A Oral pharmaceutical preparation containing ibandronat |
| 07/07/1999 | CN1222077A Fase-dissolving galanthamine hydrobromide tablet |
| 07/07/1999 | CN1222075A Biconvex rapidly disintegrating dosage forms |
| 07/07/1999 | CN1222074A Administration regimen of H+, K+-ATPase inhibitors |
| 07/07/1999 | CN1221751A Extract of mammal eyes |
| 07/07/1999 | CN1221624A Syrup for treating cough and asthma and its prodn. tech. |
| 07/07/1999 | CN1221621A Blood platelet regenerating pills and its prepn. method |
| 07/07/1999 | CN1221607A Liposoluble medicinal liposome prodn. tech. and elemene liposome injecta |
| 07/07/1999 | CN1043957C Method for prepn. of multi-unit dosage of oral medicine |
| 07/06/1999 | US5919835 Two or more polymers from the group consisting of polyesters and polyanhydrides, forming a melt, determining whether the polymers are miscible by determining if phase separation occurs when the polymer blend is dissolved in a solvent in |
| 07/06/1999 | US5919830 Non-ionic solid triblock eo/po/eo copolymer of mw=8500-25,000 and polyoxyalkylene glycol |
| 07/06/1999 | US5919822 Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients |
| 07/06/1999 | US5919821 Plant extract |
| 07/06/1999 | US5919766 Storage stability by incorporating nonionic surfactant, sodium or potassium chloride, histidine |
| 07/06/1999 | US5919757 Granulocyte colony stimulating factor mixture containingbuffer and surfactant |
| 07/06/1999 | US5919491 Calcium salt encapsulated in hydrophilic matrix polymer |
| 07/06/1999 | US5919490 Stimulating blood circulation to skin |
| 07/06/1999 | US5919489 Process for aqueous granulation of clarithromycin |
| 07/06/1999 | US5919486 Powder preparation and a process for preparing the same |
| 07/06/1999 | US5919485 Oral 2-methyl-thieno-benzodiazepine formulation |
| 07/06/1999 | US5919484 Controlled release, drug-delivery tableted composition including a polymer of a vinyl amide, (meth)acrylic acid, a long chain alkyl (meth)acrylate and a lower alkyl (meth)acrylate |
| 07/06/1999 | US5919483 Antioxidant-containing effervescent composition |
| 07/06/1999 | US5919482 Soft capsules; containiong liquid paraffin |
| 07/06/1999 | US5919481 Translucence, semi-solid |
| 07/06/1999 | US5919479 Noninvasive dermal anesthetics |
| 07/06/1999 | US5919478 Incorporating poly-N-vinyl amide in a transdermal system |
| 07/06/1999 | US5919477 Two jutaposed devices |
| 07/06/1999 | US5919473 Analgesic drug delivery |
| 07/06/1999 | US5919459 Compositions and methods for treating cancer and hyperproliferative disorders |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/06/1999 | US5919443 Stable lyophilized pharmaceutical preparations of G-CSF |
| 07/06/1999 | US5919438 Combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside |
| 07/06/1999 | US5919435 Aerosol formulation containing a particulate medicament |
| 07/06/1999 | US5919408 Process for the production of pseudolatices and micro- or nanoparticles and pharmaceutical preparations containing them |
| 07/06/1999 | US5919398 Oil-water mixed composition |
| 07/06/1999 | CA2082296C Process for the preparation of stable, complex emulsion systems of the water-oil-type and their use as cosmetic preparations |
| 07/06/1999 | CA2011063C Nicardipine pharmaceutical composition for parenteral administration |
| 07/05/1999 | CA2220038A1 Device for the delivery of high dose pharmaceutical, neutraceutical, agricultural, biological, and chemical substances |
| 07/01/1999 | WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 07/01/1999 | WO1999032540A1 Hyperbranched polymers or dendrimers having a particular group, preparation method and compositions containing same |
| 07/01/1999 | WO1999032536A1 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 07/01/1999 | WO1999032175A1 Method and device for in-situ formulation of a medicinal solution for parenteral application |
| 07/01/1999 | WO1999032158A2 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/01/1999 | WO1999032156A2 Novel sterilization process for pharmaceutical suspensions |
| 07/01/1999 | WO1999032153A1 Monoglyceride and ethyl palmitate permeation enhancer compositions |
| 07/01/1999 | WO1999032152A2 Methods for delivering pharmaceutical agents to mucosal surfaces |
| 07/01/1999 | WO1999032151A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | WO1999032146A1 Intranasal yellow fever vaccination |
| 07/01/1999 | WO1999032135A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | WO1999032131A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/01/1999 | WO1999032130A1 Medicinal plant dry extracts |
| 07/01/1999 | WO1999032128A1 Orally administrable solid ribavirin dosage forms and process for making them |
| 07/01/1999 | WO1999032126A1 Progesterone tablet and preparation method |
| 07/01/1999 | WO1999032123A1 The use of brinzolamide to prevent visual field loss |
| 07/01/1999 | WO1999032119A1 Opioid agonist/antagonist combinations |
| 07/01/1999 | WO1999032118A1 Molecular dispersion composition with enhanced bioavailability |
| 07/01/1999 | WO1999032107A1 Compositions comprising cannabinoids |
| 07/01/1999 | WO1999032096A1 Novel formulations for the transdermal administration of asimadoline |
| 07/01/1999 | WO1999032095A1 Rate controlling membranes for controlled drug delivery devices |
| 07/01/1999 | WO1999032094A1 Compositions for the transdermal and dermal administration of biologically active agents |
| 07/01/1999 | WO1999032093A1 Oral pharmaceutical pulsed release dosage form |
| 07/01/1999 | WO1999032092A1 Process for manufacturing bite-dispersion tablets |
| 07/01/1999 | WO1999032091A1 Oral pharmaceutical extended release dosage form |
| 07/01/1999 | WO1999032090A1 Method and device for producing pharmaceutical formulations containing an extract |
| 07/01/1999 | WO1999032089A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | WO1999032088A1 Aqueous insecticidal pour-on formulation |
| 07/01/1999 | WO1999032087A1 Water-soluble eye drop |
| 07/01/1999 | WO1999032086A1 Solvent/surfactant insecticidal pour-on formulation |
| 07/01/1999 | WO1999032085A2 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | WO1999032084A1 Compositions for the treatment of skin and anorectal conditions |
| 07/01/1999 | WO1999032083A1 Microparticles and their therapeutic or diagnostic use |
| 07/01/1999 | WO1999032082A2 Pharmaceutical compositions |
| 07/01/1999 | WO1999032081A1 Transmucosal formulations of levosimendan |
| 07/01/1999 | WO1999031987A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | WO1999020244A3 Method for transdermal application of active substances at high, constant dosis |
| 07/01/1999 | WO1999018933A3 Methods for encapsulating nucleic acids in lipid bilayers |
| 07/01/1999 | DE19830528A1 Multi-layer tablet comprising nutritious substances and microorganisms, and can be stored without cooling |
| 07/01/1999 | DE19758100A1 Verfahren zum Herstellen von Extrakt enthaltenden pharmazeutischen Formulierungen A process for the manufacture of pharmaceutical formulations containing extract |
| 07/01/1999 | DE19757224A1 Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation Method and apparatus for in-situ formulation of a medicinal substance solution for parenteral administration |
| 07/01/1999 | DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide |
| 07/01/1999 | DE19756235A1 Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide New piperidinylsubstituierte pyridylalkane alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19752843A1 Pantoprazole and omeprazole film tablet and pellet used for treating conditions associated with elevated gastric acid secretion |
| 07/01/1999 | CA2316248A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | CA2316171A1 Microparticles and their therapeutic or diagnostic use |
| 07/01/1999 | CA2316018A1 Novel pharmaceutical compositions of uridine triphosphate |
| 07/01/1999 | CA2316015A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | CA2315782A1 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant |
| 07/01/1999 | CA2315238A1 Method and device for producing pharmaceutical formulations containing an extract |
| 07/01/1999 | CA2315088A1 Process for manufacturing bite-dispersion tablets |
| 07/01/1999 | CA2314868A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | CA2313316A1 Compositions comprising cannabinoids |
| 07/01/1999 | CA2313163A1 Pharmaceutical compositions |
| 07/01/1999 | CA2312040A1 Hyperbranched polymers or dendrimers having a particular group, preparation method and compositions containing same |
| 07/01/1999 | CA2310698A1 Novel sterilization process for pharmaceutical suspensions |
| 06/30/1999 | EP0926185A1 Copolymer of succinimide/ hydroxycarboxylic acid and process for preparing the same |
| 06/30/1999 | EP0925789A1 Topical azithromycin compositions for the treatment of ocular infections |
| 06/30/1999 | EP0925293A1 Method of producing an extruded nutritional supplement product |
| 06/30/1999 | EP0925076A1 Implant consisting of a carrier material containing medical substances and method to produce such an implant |
| 06/30/1999 | EP0925066A2 Pharmaceutical compositions |
| 06/30/1999 | EP0925065A1 Water miscible erythromycin solutions |